Qualigen Therapeutics, Inc. (QLGN)
NASDAQ: QLGN · Real-Time Price · USD
1.670
-0.010 (-0.60%)
At close: Aug 13, 2025, 4:00 PM
1.680
+0.010 (0.60%)
Pre-market: Aug 14, 2025, 8:07 AM EDT
Qualigen Therapeutics Employees
Qualigen Therapeutics had 4 employees as of December 31, 2023. The number of employees decreased by 34 or -89.47% compared to the previous year.
Employees
4
Change (1Y)
-34
Growth (1Y)
-89.47%
Revenue / Employee
n/a
Profits / Employee
-$1,725,050
Market Cap
2.73M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4 | -34 | -89.47% |
| Dec 31, 2022 | 38 | -8 | -17.39% |
| Dec 31, 2021 | 46 | 8 | 21.05% |
| Dec 31, 2020 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
QLGN News
- 16 days ago - Qualigen Therapeutics Announces $4.5 Million Private Placement of Series A-3 Convertible Preferred Stock - GlobeNewsWire
- 3 months ago - Qualigen Therapeutics, Inc. receives expected notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q - GlobeNewsWire
- 3 months ago - Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K - GlobeNewsWire
- 9 months ago - Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN) - GlobeNewsWire
- 10 months ago - Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024 - GlobeNewsWire
- 11 months ago - Qualigen Therapeutics, Inc. Announces management changes. - GlobeNewsWire
- 11 months ago - Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel - GlobeNewsWire
- 1 year ago - Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN) - GlobeNewsWire